हिंदी में पढ़ें
Income Tax Calculator
Personal Loan Calculator
Car Loan Calculator
Home Loan Calculator
MF Returns Calculator
Bharat Biotech News
Factsheet released on Corona Vaccine, know who should not get vaccinated
Tue, Jan 19, 2021
Bharat Biotech and Serum Institute released a factsheet about Corona Vaccine, which tells about who should get the vaccine and who should not.
From Bharat Biotech Covaxin, AstraZeneca/Oxford/ Serum Institute' Covishield and much more: EXPLAINED
Mon, Jan 04, 2021
Bharat Biotech's Covaxin is an exception as it is still in Phase-3 and yet to complete trial recruitment. No interim analysis of efficacy is available and pre-print Phase-1/2 data have only given details on immunogenicity and not efficacy of the vaccine. The emergency use approval, even as a back-up vaccine, is therefore highly unusual. Government authorities have announced that Serum's Covishield will remain the primary vaccine for the time being and Bharat Biotech's Covaxin will be in back-up, only to be used in case of a surge in case.
This Covid-19 vaccine safest with less allergic reactions - Bharat Biotech reveals
Mon, Dec 21, 2020
Covid-19 vaccine: Bharat Biotech has claimed that amongst all the vaccine platforms such as an mRNA-based vaccine, DNA-based vaccine, vector-based vaccine, or live attenuated vaccines, etc., the inactivated vaccines being developed by it for Covid 19 are safest, and hence, the adverse reactions are lesser.
Bharat Biotech's COVID-19 vaccine 'Covaxin' into phase-3 trials
Mon, Nov 16, 2020
COVID-19 vaccine - Covaxin - being developed by Bharat Biotech, is now undergoing phase-3 trials, Chairman and Managing Director of the company Krishna Ella said on Monday.
Bharat Biotech in talks to take COVID-19 vaccine candidate COVAXIN global
Fri, Oct 23, 2020
Bharat Biotech is in discussions with more than 10 countries that have shown an interest in a potential COVID-19 vaccine it is developing with a government agency, a company executive told Reuters on Friday.
Stage is set for phase II trials of Bharat Biotech's COVID vaccine
Sun, Sep 06, 2020
The stage is set for phase II clinical trials of Bharat Biotech's coronavirus vaccine from Monday.